10.1016/j.yexcr.2016.03.026 Exp
Implications for therapeutic use The pharmacokinetic differences between SLU-PP-332 and 5-amino-1mq have significant implications for their therapeutic use: Dosing frequency: The rapid absorption and extensive distribution of SLU-PP-332 may allow for less frequent dosing compared to 5-amino-1mq
The BPC 157 dose and application regimens (10 g or 10 ng/kg given as an intragastric administration or continuously orally, in drinking water) were as described previously (i.e., without use of a carrier or peptidase inhibitor) (for review, see, i.e., [1,2,3,4,5,6])
Start with the loading phase and give it the full 4-6 weeks before deciding if its working
But if dullness is caused by a lack of Vitamin B12, injections may work just as well or even better
Protecting probiotic bacteria by microencapsulation: Challenges for industrial applications